Skip to evidence report

T.CD4_Tem.long_term_memory: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 3,161 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for T.CD4_Tem.long_term_memory
#Trait / studyIndividual trait IDMean IC score
1Psoriasis vulgaris (PheCode 696.41)GCST9047619070.11
2Psoriasis and related disorder (PheCode 696)GCST9047618668.40
3Psoriasis (PheCode 696.4)GCST9047618766.67
4Psoriatic arthritisGCST9024395666.26
5CXCL9 levelsGCST9046893562.05
6Allergic contact dermatitisFING0000006860.98
7Asthma | Chronic lower respiratory diseasesUKBB0000005360.91
8Nasal polypFING0000085860.12
9CD5/TNFRSF9 ratioGCST9031386259.81
10Asthma-related infectionsFING0000011859.42
11Asthma | respiratoryUKBB0000005458.84
12Second line medication for Crohn's diseaseFING0000128456.69
13Asthma-related acute respiratory infectionsFING0000011756.54
14Asthma/COPD (KELA code 203)FING0000012154.51
15MS-disease / Multiple SclerosisFING0000083954.07
16PALM2 levelsGCST9047015253.86
17Asthma (only as main-diagnosis) (more control exclusions)FING0000011453.84
18Papulosquamous disordersFING0000114453.27
19Multiple sclerosisGCST9047583351.51
20Hypothyroidism | endocrine/metabolicUKBB0000033551.49
21Suggestive for eosinophilic asthmaFING0000134451.13
22Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB0000051850.34
23Reimbursement for rheumatic diseasesFING0000124750.15
24FCRL6 levelsGCST9046920949.49
25Other hypothyroidism | Disorders of thyroid glandUKBB0000061149.35
26Chronic lower respiratory diseasesFING0000029049.34
27TNFRSF8 levelsGCST9047091549.26
28HypothyroidismGCST9046813848.75
29Hypothyroidism NOS | endocrine/metabolicUKBB0000033648.57
30TXNL1 levelsGCST9047099347.75
31HypothyroidismGCST9020416747.75
32Treatment/medication code - levothyroxine sodium | MedicationsUKBB0000084947.42
33Thyroid problemsGCST9047527647.40
34CXCL16 levelsGCST9046892847.33
35Atopic dermatitisFING0000012547.26
36Asthma (more control exclusions)FING0000011346.87
37Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST9062475046.42
38Autoimmune diseases excluding thyroid diseasesFING0000013245.73
39Rheumatoid arthritisFING0000126745.61
40Chronic sinusitisFING0000029845.55
41Autoimmune diseasesFING0000013145.12
42Type 1 diabetesGCST9000052944.86
43CD48/CRTAM ratioGCST9031383944.63
44AsthmaGCST9046811244.47
45Psoriasis vulgarisFING0000122443.60
46Asthma (childhood onset)GCST00780043.34
47PAFAH1B3 levelsGCST9047014543.12
48Lymphocyte countGCST9002598442.85
49Atopic dermatitisGCST9002716142.77
50CRTAM/VCAM1 ratioGCST9031428142.67
51OSMR levelsGCST9047013242.63
52AsthmaGCST01004242.55
53Disorders of the thyroid glandFING0000046342.55
54Prescriptions - levothyroxine | thyroid hormoneUKBB0000068742.55
55Prescriptions - thyroid hormone | hormoneUKBB0000070542.55
56Type 1 diabetesGCST9001379142.36
57Thyroid peroxidase antibody positivity in pregnancyGCST9043520242.26
58Hypothyroidism NOS (PheCode 244.4)GCST9047565342.12
59Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST9004253541.98
60PsoriasisGCST9001901641.72
61Thyroid peroxidase antibody levels in pregnancyGCST9043520141.62
62Hypothyroidism (PheCode 244)GCST9047564741.40
63Dermatitis and eczemaFING0000040241.36
64Allergic asthma (mode)FING0000006641.12
65GZMA/GZMB ratioGCST9031500740.64
66Diseases of hair and hair follicles (PheCode 704)GCST9047620940.54
67Takes medication for Thyroid problems?GCST9047527740.45
68Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB0000050940.33
69AsthmaGCST9001432540.29
70Lymphoid neoplasms (B-cell phenocluster)GCST9062473640.00
71Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB0000009839.65
72Type 1 diabetesGCST9001402339.54
73HypothyroidismGCST9031932039.10
74NCR1 levelsGCST9047000938.71
75CD5 levelsGCST9046864138.70
76IDO1 levelsGCST9046950638.68
77RBFOX3 levelsGCST9047043238.68
78Eosinophill count | Blood countUKBB0000020638.59
79CD160/CXCL16 ratioGCST9031372838.44
80Hypothyroidism, strict autoimmuneFING0000065638.24
81Noninfective enteritis and colitisFING0000088138.17
82Lymphocyte countGCST9001874238.13
83Other/unspecified rheumatoid arthritisFING0000112638.12
84Nasal polyps | respiratoryUKBB0000049437.88
85Lymphoid neoplasmsGCST9062474337.78
86Asthma and allergyFING0000011537.73
87CD160/KLRB1 ratioGCST9031373137.70
88Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB0000050637.61
89Asthma (adult onset)GCST00779937.55
90Basal cell carcinoma (MTAG)GCST9013741137.15
91Eosinophill percentage (UKB data field 30210)GCST9046806937.09
92GZMH levelsGCST9046942536.78
93CCL17/PDGFB ratioGCST9031368836.53
94AsthmaGCST00686236.40
95CD244/CRTAM ratioGCST9031376336.33
96Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST9043520336.31
97PsoriasisFING0000122235.99
98RPE levelsGCST9047049535.98
99Lymphoid neoplasms (drug group 1 phenocluster)GCST9062474035.95
100HippSubfield lh volume Hippocampal-tailGCST9000266835.90
101lymphocyte (absolute count, maximum, inv-norm transformed)GCST9047542335.80
102Lymphocyte countGCST9000231735.76
103eosinophil (absolute count, mean, inv-norm transformed)GCST9047529135.68
104Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB0000010135.51
105Pain type(s) experienced in last month - Pain all over the body | PainUKBB0000063235.04
106EndometriosisGCST9001861935.01
107Allergic disease (asthma, hay fever or eczema)GCST00503834.85
108GZMA/GZMH ratioGCST9031500834.78
109Eosinophill percentage | Blood countUKBB0000020734.65
110Eosinophil countGCST00460634.62
111Graves disease, strict definitionFING0000059234.39
112Coeliac diseaseGCST9046812034.26
113lymphocyte (absolute count, mean, inv-norm transformed)GCST9047542634.17
114eosinophil (absolute count, minimum, inv-norm transformed)GCST9047529433.96
115CD160/NCR1 ratioGCST9031373233.96
116Nasal polyps (PheCode 471)GCST9047601933.83
117Other (seronegative) rheumatoid arthritis, wideFING0000091733.83
118CRTAM/LY9 ratioGCST9031427833.82
119ThyrotoxicosisFING0000136033.77
120eosinophil (absolute count, maximum, inv-norm transformed)GCST9047528833.72
121Seropositive rheumatoid arthritis, wideFING0000129833.53
122Childhood asthma (age<16) (more control exclusions)FING0000027033.51
123Eosinophil percentage of granulocytesGCST00461733.17
124CD79B/TNFRSF4 ratioGCST9031390333.01
125Respiratory disease (confirmatory factor analysis Factor 11)GCST9030934533.01
126Eosinophil percentage of white cellsGCST00460032.87
127Other diseases of upper respiratory tractFING0000101232.86
128GZMB levelsGCST9046942432.78
129Seropositive rheumatoid arthritis, strict definitionFING0000129732.64
130First line medication for Crohn's diseaseFING0000054432.34
131Nasal polyp | Other diseases of upper respiratory tractUKBB0000049332.33
132Rheumatoid arthritisGCST9013222432.22
133SKAP1 levelsGCST9047064532.17
134Eosinophil percentage of white cellsGCST9000238231.99
135Eosinophil countGCST9001873331.79
136Mouth/teeth dental problems - Mouth ulcers | MouthUKBB0000048831.60
137Neutrophil percentage of granulocytesGCST00462331.52
138Crohn disease (strict definition, require KELA, min 2 HDR)FING0000036631.49
139Eosinophill count (UKB data field 30150)GCST9046806831.44
140aseg lh volume HippocampusGCST9000262431.26
141Sum eosinophil basophil countsGCST00462431.26
142eosinophil (fraction, minimum, inv-norm transformed)GCST9047530331.09
143Ceramide (d18:2/22:0) levelsGCST9002468231.03
144Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST9047606530.71
145ITGAL levelsGCST9046963730.63
146NBN levelsGCST9047000230.61
147Eosinophil countGCST9000229830.53
148Lymphocyte count | Blood countUKBB0000041130.52
149Other demyelinating diseases of the central nervous systemFING0000099530.49
150ACYP1 levelsGCST9046821430.39
151TNFRSF17 levelsGCST9047090830.39
152Eosinophil countGCST9000238130.16
153IL15 levelsGCST9046955630.02
154eosinophil (fraction, maximum, inv-norm transformed)GCST9047529730.01
155Rheumatoid arthritisGCST9013222330.00
156Eosinophil countGCST9000229929.99
157Lymphocyte count (UKB data field 30120)GCST9046808229.79
158CRTAM/FCRL6 ratioGCST9031427429.71
159CD160 levelsGCST9046859929.64
160Blood cell traits latent factor 9 (white cell)GCST9055925129.58
161eosinophil (fraction, mean, inv-norm transformed)GCST9047530029.46
162Lymphocyte countGCST9000231629.45
163DTI TBSS L3 Sagittal stratum LGCST9038455529.35
164Hypothyroidism, drug reimbursementFING0000065529.29
165Mosaic chromosomal alteration of the X chromosomeGCST9016528729.25
166Allergy/adverse effect of penicillin | injuries & poisoningsUKBB0000002829.17
167LAT/LYN ratioGCST9031528329.10
168Rheumatoid arthritisGCST9001869029.09
169Obesity related asthmaFING0000089729.09
170Lymphocyte countGCST9000238828.97
171lymphocyte (absolute count, minimum, inv-norm transformed)GCST9047542928.96
172Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING0000075628.86
173PCBD1 levelsGCST9047016628.75
174Seborrheic dermatitis (PheCode 690.1)GCST9047617128.75
175Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB0000010028.64
176GZMB/IL15 ratioGCST9031501528.64
177PsoriasisGCST9046814728.61
178Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030270628.55
179CD8A levelsGCST9046865528.42
180HyperthyroidismGCST9046813628.42
181HLAE/IL15 ratioGCST9031506128.36
182EczemaGCST9046812628.34
183BLNK levelsGCST9046844828.17
184MZB1 levelsGCST9046998728.14
185CD6 levelsGCST9046864428.11
186CXCL16/NOTCH1 ratioGCST9031433928.06
187HSIL lesion of the cervix uteriFING0000062427.96
188Erythematosquamous dermatosis (PheCode 690)GCST9047617027.87
189CLC levelsGCST9046876227.69
190Blood cell traits latent factor 17 (white cell)GCST9055925927.66
191SarcoidosisGCST9050348327.49
192Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB0000051327.44
193Overweight, obesity and other hyperalimentation | endocrine/metabolicUKBB0000062227.41
194GNLY levelsGCST9046937227.39
195Thyrotoxicosis with diffuse goitreFING0000136127.31
196PDCD1/TNFRSF8 ratioGCST9031561027.30
197GNLY/GZMA ratioGCST9031494927.16
198LTA levelsGCST9046981327.12
199Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239627.05
200DTI TBSS MD Superior corona radiata LGCST9038459726.92
201Type1 diabetes, definitions combined, early onsetFING0000138426.83
202CXCL10 levelsGCST9046892326.79
203Inflammatory bowel disease, strict (require KELA)FING0000067526.69
204Systemic lupus erythematosusGCST9001186626.53
205CRTAM levelsGCST9046887126.47
206Lymphocyte countGCST00462726.43
207LHPP levelsGCST9046976826.35
208PDCD1 levelsGCST9047018126.30
209HSIL lesion of the cervix uteri, vagina or vulvaFING0000062526.25
210CD101 levelsGCST9046859625.90
211Type 1 diabetesGCST9043206625.87
212HippSubfield lh volume Whole-hippocampusGCST9000268925.83
213Neurofibromatosis, type 2FING0000086725.81
214AsthmaGCST9047525925.72
215Blood cell traits latent factor 3 (white cell)GCST9055924525.70
216Seronegative rheumatoid arthritisFING0000129625.44
217Pulmonary fibrosisGCST9001868825.42
218Primary biliary cholangitis (PBC)FING0000121125.29
219PolyarthropathiesFING0000118025.15
220Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB0000070625.14
221Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB0000069425.14
222Left-hemisphere control network to amygdala white-matter structural connectivityGCST9030275725.00
223IL5RA/TNFRSF13B ratioGCST9031516424.78
224ROR1/THBD ratioGCST9031578624.78
225S100A11/S100A12 ratioGCST9031579824.76
226KLRF1 levelsGCST9046971224.75
227ICD10 N84: Polyp of female genital tractGCST9045421624.74
228Acute upper respiratory infectionsFING0000003424.56
229Disorders of orbitFING0000044924.54
230Asthma with exacerbation (PheCode 495.2)GCST9047602524.45
231Monoclonal gammopathy of undetermined significanceGCST9062474524.42
232KLRB1 levelsGCST9046970924.37
233HippSubfield lh volume GC-ML-DG-headGCST9000267924.37
234Infective dermatitisFING0000067324.26
235SH2B3/TBL1X ratioGCST9031584124.24
236Primary biliary cholangitisGCST9006144024.12
237SNRPB2 levelsGCST9047069724.11
238Omega-3 fatty acids to total fatty acids percentageGCST9050246024.09
239MAVS/TBL1X ratioGCST9031539923.72
240AsthmaGCST9047602423.71
241Wheeze or whistling in the chest in last year | BreathingUKBB0000091223.66
242GZMA/TNFRSF8 ratioGCST9031501423.66
243IL2RB levelsGCST9046958623.61
244KLRK1 levelsGCST9046971323.51
245IridocyclitisFING0000069623.48
246KLF4 levelsGCST9046969423.46
247aparc-a2009s rh thickness G-temporal-middleGCST9000371423.42
248HippSubfield lh volume Whole-hippocampal-bodyGCST9000268723.42
249IPCEF1/SERPINE1 ratioGCST9031518423.38
250PDCD5 levelsGCST9047018223.37
251ELOA/POLR2F ratioGCST9031464323.30
252DKK1/IPCEF1 ratioGCST9031447123.30
253Obesity | endocrine/metabolicUKBB0000054423.19
254Seborrhoeic dermatitisFING0000128223.18
255Obesity | Obesity and other hyperalimentationUKBB0000054523.12
256ATOX1/SNAP29 ratioGCST9031337423.11
257Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000064123.09
258CD244/FCRL6 ratioGCST9031376523.09
259Rash and other nonspecific skin eruption (PheCode 687.1)GCST9047616723.07
260Celiac disease (PheCode 557.1)GCST9004415823.00
261IL1RL1 levelsGCST9046957422.94
262DTI autoptx MD cgc l tractGCST9038522422.88
263SH3GLB2 levelsGCST9047062122.84
264CD5/IL16 ratioGCST9031386122.83
265BMP7 levelsGCST9008815722.79
266COPD/asthma/ILD related infectionsFING0000035322.77
267Other noninfective gastroenteritis and colitisFING0000107722.73
268Sicca syndrome [Sjögren]FING0000130422.66
269Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST9009311322.65
270Blood cell traits latent factor 12 (red cell)GCST9055925422.62
271T1 FreeSurfer aseg MaskVol-to-eTIVGCST9038419222.57
272Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST9013222722.51
273GZMA/TNFRSF4 ratioGCST9031501322.51
274KDM3A levelsGCST9046967122.46
275GRAP2/SRC ratioGCST9031498922.43
276F2R/SNX9 ratioGCST9031473622.40
277PAG1 levelsGCST9047014722.38
278DNAJC21 levelsGCST9046901622.31
279HayfeverGCST9046813122.21
280Chronic dermatitis due to solar radiation (PheCode 938.2)GCST9047628822.14
281Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST9047628922.07
282ChalazionFING0000026721.95
283Disorders of sclera, cornea, iris and ciliary bodyFING0000045821.88
284Ceramide (d18:2/22:0) levelsGCST9002405421.82
285TRAF2/WWP2 ratioGCST9031594321.82
286Type 1 diabetes, definitions combinedFING0000138021.72
287Eosinophil count varianceGCST9056568921.71
288HippSubfield lh volume GC-ML-DG-bodyGCST9000268121.58
289C5 levelsGCST9046850021.56
290Benign leiomyoma with endometriosis (controls excluding all cancers)FING0000014521.39
291FCRL5/LY96 ratioGCST9031480321.36
292CD48/SLAMF7 ratioGCST9031384221.36
293HippSubfield lh volume CA4-headGCST9000268221.27
294CRTAP levelsGCST9046887221.26
295Other acute lower respiratory infectionsFING0000092121.22
296Inflammatory bowel diseaseGCST9043218221.01
297DTI TBSS L3 Cingulum hippocampus RGCST9038456021.00
298Omega-3 fatty acids to total fatty acids percentageGCST9050244820.95
299Graves' disease (PheCode 242.1)GCST9047564420.87
300Wheeze or whistling in the chest in last year (UKB data field 2316)GCST9004361420.84
301Ulcerative colitisGCST9001871320.82
302CRTAM/PDCD1 ratioGCST9031427920.77
303X-21285 levelsGCST9020057620.72
304IL15/IL18BP ratioGCST9031514820.72
305CRTAM/GZMA ratioGCST9031427520.72
306DNA methylation PhenoAge accelerationGCST9001429220.70
307RILP levelsGCST9047047120.62
308SIT1 levelsGCST9047064420.62
309Ulcerative colitis (PheCode 555.2)GCST9004415520.59
310Peripheral or central vertigo (PheCode 386.2)GCST9047590720.59
311CD27/DLL1 ratioGCST9031377120.55
312Lichen sclerosus et atrophicusFING0000072320.52
313ICD10 N87: Dysplasia of cervix uteriGCST9045421820.50
314Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB0000037120.48
315HippSubfield lh volume CA4-bodyGCST9000268320.42
316Operation code - tonsillectomy +/- adenoids | OperationsUKBB0000056720.32
317SarcoidosisFING0000127520.25
318GRHPR levelsGCST9046940020.24
319Asthma-related pneumoniaFING0000011920.23
320Systemic connective tissue disordersFING0000135020.22
321Smoking status (weighted GWA)GCST9026730320.22
322Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB0000086020.05
323APRT levelsGCST9046834520.03
324CD48/FCRL6 ratioGCST9031384020.01
325Non-albumin protein levelsUKBB0000050319.99
326IL18 levelsGCST9042841119.93
327Bipolar disorderGCST00372419.85
328CD27/TGFBR2 ratioGCST9031377619.83
329IFNG levelsGCST9046951519.76
330BOC levelsGCST9046845819.71
331DermatitisFING0000040119.70
332ENO2/RWDD1 ratioGCST9031466719.67
333MZB1/TNFRSF13B ratioGCST9031550919.65
334Skin cancerGCST9047557519.55
335AHSP/HMBS ratioGCST9031321719.48
336Acute pancreatitisFING0000002719.45
337Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)FING0000077719.41
338ERBIN/LYN ratioGCST9031469419.37
339Primary biliary cholangitisGCST00312919.36
340TNFRSF11A levelsGCST9027764419.23
341FOXO3 levelsGCST9046926619.23
342Medication use (drugs affecting bone structure and mineralization)GCST9001877319.21
343Mouth/teeth dental problems - None of the above | MouthUKBB0000048919.21
344Lung cancerGCST9001865519.21
345CRTAM/ICAM3 ratioGCST9031427619.16
346Early-onset myasthenia gravisGCST9009346519.12
347Blood cell traits latent factor 20 (red cell)GCST9055926219.10
348Autoimmune hyperthyroidismFING0000013419.05
349T1 FreeSurfer DK rh supramarginal volumeGCST9038578719.05
350DNAJB2 levelsGCST9046901319.03
351Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB0000001518.97
352CD8 on Effector Memory CD8+ T cellGCST9000205618.94
353GZMA/LTA ratioGCST9031501218.94
354Ulcerative colitisGCST9047532218.93
355Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB0000019218.92
356CCR2 on CD14+ CD16- monocyteGCST9000200418.91
357SRP14 levelsGCST9047074218.91
358LBR/LGALS8 ratioGCST9031529418.91
359Non-allergic asthma (mode) (more control exclusions)FING0000086918.89
360Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING0000114318.89
361STX6 levelsGCST9047077418.88
362SMNDC1 levelsGCST9047068118.87
363MSRA/PRDX5 ratioGCST9031549718.86
364BCL2 levelsGCST9046843318.83
365BOLA2 or BOLA2B levelsGCST9046846018.78
366ICD10 O60: Preterm labor and deliveryGCST9045424218.74
367Crohn's disease NASFING0000036718.68
368Diseases of white blood cells (PheCode 288)GCST9047581218.67
369MPHOSPH8/USP8 ratioGCST9031547918.63
370mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544418.56
371PM: initial answer - Orange circle| Prospective memoryUKBB0000065218.55
372LTA4H levelsGCST9046981218.52
373Chronic hepatitis B infectionGCST9001858418.49
374Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB0000005918.46
375Eosinophil countGCST9002598718.40
376HyperthyroidismGCST9031931918.39
377Vitamin B12 deficiency anaemiaFING0000144118.39
378Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066852418.38
379IDP T1 FIRST left hippocampus volumeGCST9000244418.33
380Lymphocyte percentage | Blood countUKBB0000041218.33
381Lichen simplex chronicus and prurigoFING0000072518.30
382Internal derangement of knee (PheCode 835)GCST9047628218.27
383Principal component-derived dietary pattern 9GCST9013301418.18
384Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST9062474618.17
385FOXO3/SH2B3 ratioGCST9031488118.17
386Crohns diseaseGCST9046812118.12
387GBP1 levelsGCST9046931118.09
388Cervical cancerGCST9001181618.07
389Rheumatoid arthritisGCST00067918.06
390Lichen ruber planus, wide definition including periferal and oral lichen planusFING0000072217.93
391TALDO1 levelsGCST9047080217.92
392APBB1IP/POLR2F ratioGCST9031330017.87
393FCRL6/GZMA ratioGCST9031480617.82
394IFI30 levelsGCST9046950917.82
395GZMH/KLRD1 ratioGCST9031501617.68
396Basal cell carcinoma (PheCode 172.21)GCST9047558217.64
397SPINK2 levelsGCST9047072217.64
398Lymphocyte percentage (UKB data field 30180)GCST9046808317.62
399CRTAM/TNFRSF9 ratioGCST9031428017.60
400CD27/NBL1 ratioGCST9031377417.56
401CD244 levelsGCST9046861117.52
402ALB/Globulin ratioUKBB0000002017.30
403Graves' diseaseGCST9001862717.26
404CD300A levelsGCST9046861917.18
405Chromatiales abundance in stoolGCST9003231817.13
406Lymphocyte percentage of white cellsGCST9000238917.08
407Volume of right central nucleusGCST9047491617.04
408Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST9066848517.01
409PDCD1/TNFRSF4 ratioGCST9031560916.97
410Paraproteinemia (PheCode 270.32)GCST9047571016.95
411EZR levelsGCST9046916216.90
412Frequency of stair climbing in last 4 weeks | Physical activityUKBB0000026616.88
413GFRA2 levelsGCST9046932916.87
414FCRL5/TNFRSF13B ratioGCST9031480516.84
415Basal cell carcinomaGCST9001341016.84
416Nasal polypsGCST9046814316.79
417Prescriptions - albuterol | beta2-agonist,bronchodilator,asthmaUKBB0000065816.79
418Prescriptions - beta2-agonist|bronchodilator|asthmaUKBB0000067016.79
419Coeliac diseaseFING0000031216.78
420DNMBP/WWP2 ratioGCST9031452216.76
421KCTD5 levelsGCST9046967016.75
422Idiopathic pulmonary fibrosisFING0000065916.74
423CCL17/CD69 ratioGCST9031368416.70
424CD7 levelsGCST9046864916.70
425Other non-epithelial cancer of skin (PheCode 172.2)GCST9047558016.66
426Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB0000030216.66
427Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB0000083716.65
428SLITRK2 levelsGCST9047067016.58
429CCL8 levelsGCST9042234616.57
430Preterm labour and deliveryFING0000120916.55
431Other specified disorders of external earFING0000110416.52
432Mean corpuscular hemoglobin concentrationGCST9001874516.51
433RIDA levelsGCST9047046916.45
434MAN2B2 levelsGCST9046984416.42
435IDP dMRI ProbtrackX L1 str lGCST9000426916.34
436Urine N-acetylglutamate levels in chronic kidney diseaseGCST9026556916.31
437Cerebrospinal fluid methylmalonate (MMA) levelsGCST9031824316.29
438Lymphoid neoplasms (P-cell phenocluster)GCST9062473716.29
439Primary sclerosing cholangitisGCST00403016.20
440HSPA1A levelsGCST9046948716.20
441HEXIM1/TRIAP1 ratioGCST9031505416.06
442Crohn's diseaseGCST9044679316.00
443Rheumatoid arthritis | musculoskeletalUKBB0000075715.98
444Rhodanobacter abundance in stoolGCST9003253615.98
445Lumbar disc prolapseFING0000073515.96
446PollinosisGCST9001868315.94
447STIP1 levelsGCST9047076415.94
448DTI TBSS MD Posterior limb of internal capsule LGCST9038459115.90
449Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST9030936915.89
450DTI TBSS MD Cingulum cingulate gyrus LGCST9038460715.88
451Poisoning by antibiotics | injuries & poisoningsUKBB0000065315.87
452CCL19 levelsGCST9046857115.84
453Blood cell traits latent factor 23 (white cell)GCST9055926515.78
454PTPRC levelsGCST9047038015.73
455Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST9047559315.68
456IL5RA levelsGCST9046960015.67
457Squamous cell carcinoma (PheCode 172.22)GCST9047558315.59
458DTI TBSS L1 Cingulum cingulate gyrus LGCST9038446315.58
459IL22 levelsGCST9046958215.57
460Endometrial cancerGCST00646415.49
461TRAF3 levelsGCST9047095715.48
462IGLC2 levelsGCST9046953615.43
463MAVS/MED18 ratioGCST9031538915.40
464Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletalUKBB0000075815.32
465Solitary pulmonary nodule (PheCode 514.2)GCST9047604415.31
466PEAR1/PECAM1 ratioGCST9031564115.29
467CD48 levelsGCST9046863515.21
468Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST9047590515.12
469Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classifiedFING0000043215.05
470TIGIT levelsGCST9047086515.04
471Nonspecific chest pain | circulatory systemUKBB0000052715.03
472ENO3 levelsGCST9046911114.99
473CXCL11/DKK1 ratioGCST9031433414.94
474CD27/NECTIN4 ratioGCST9031377514.91
475Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST9026483214.90
476IDP dMRI TBSS L1 Posterior limb of internal capsule RGCST9000409314.88
477GSTA4 levelsGCST9024128314.87
478Triacylglycerol_52:5_[M+NH4]1+ levelsGCST9006050614.85
479Number of attempts | Prospective memoryUKBB0000053114.74
480MelanomaGCST9001180914.74
481lymphocyte (fraction, maximum, inv-norm transformed)GCST9047543214.73
482Psoriatic arthropathiesFING0000122514.72
483DTI autoptx MD str r tractGCST9038524414.71
484FCRL5/ICAM3 ratioGCST9031480214.71
485PSAPL1 levelsGCST9024235414.70
486PAXX levelsGCST9047016114.68
487Sporadic miscarriageGCST01188814.68
488Mean corpuscular hemoglobin concentrationGCST9000232914.65
489mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047544814.54
490ARG1 levelsGCST9046835014.54
491RAPGEF2 levelsGCST9047042614.52
492CD40LG/TRAF2 ratioGCST9031382814.49
493SMPD3 levelsGCST9047068514.46
494Diseases of the digestive systemFING0000042914.45
495Myasthenia gravisGCST9043215614.45
496T1 FreeSurfer DKT rh supramarginal volumeGCST9038437714.44
497Mean reticulocyte volume | Blood countUKBB0000045114.44
498Ankylosing spondylitisFING0000008914.43
499Other haemoglobinopathiesFING0000105314.42
500TNFRSF19 levelsGCST9008894714.38
501Ulcerative rectosigmoiditisFING0000139414.35
502TNFSF12 levelsGCST9027484614.31
503Ulcerative colitisGCST00413314.31
504Red blood cell countGCST9001875114.29
505Mood swings | Mental healthUKBB0000048214.27
506SELPLG levelsGCST9047056814.26
507Chronic lymphocytic leukemiaGCST9062473814.23
508Melanomas of skin, dx or hx (PheCode 172.1)GCST9047557714.22
509AXIN1/MAVS ratioGCST9031341414.20
510Allergic rhinitisFING0000007114.20
511AK1 levelsGCST9046826914.19
512GZMA levelsGCST9046942314.18
513PLXNB3/SNAP23 ratioGCST9031569314.17
514CEP85 levelsGCST9046871614.16
515Crohn's disease of small intestineFING0000036914.14
516SH2D1A levelsGCST9047061714.09
517CDH17/PTPRM ratioGCST9031394314.07
518lymphocyte (fraction, mean, inv-norm transformed)GCST9047543514.07
519PRG2 levelsGCST9047032214.04
520Erythematous conditions (PheCode 695)GCST9047617713.99
521Prescriptions - paracetamol | antipyreticUKBB0000069613.97
522Prescriptions - antipyreticUKBB0000066513.97
523T1 FreeSurfer BA lh BA2 exvivo volumeGCST9038553413.94
524EDAR/TACC3 ratioGCST9031458913.92
525Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST9026604013.90
526GRAP2/MAP4K5 ratioGCST9031498213.89
527Juvenile rheumatoid arthirtisFING0000070613.89
528PEBP1 levelsGCST9047020513.89
529Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST9030935813.87
530Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030281113.87
531DNA methylation-estimated granulocyte proportionsGCST9001428713.84
532Other intervertebral disc disordersFING0000106313.81
533FASLG levelsGCST9046919113.79
534Acute upper respiratory infections of multiple and unspecified sitesFING0000003513.78
535lymphocyte (fraction, minimum, inv-norm transformed)GCST9047543813.75
536DTI TBSS MD Posterior thalamic radiation RGCST9038460013.73
537PM: initial answer - Blue square | Prospective memoryUKBB0000065113.66
538Biological Sibling: AsthmaGCST9047637213.63
5393-methyl-2-oxobutyrate levelsGCST9019967713.62
540Treatment/medication code - ibuprofen | MedicationsUKBB0000084713.61
541aparc-a2009s rh thickness G-oc-temp-med-LingualGCST9000369813.59
542Psoriasis (vulgaris), strict definitionFING0000122313.56
543DTI TBSS MD Superior longitudinal fasciculus RGCST9038461213.53
544CDA levelsGCST9046866013.52
545LCN2/S100A12 ratioGCST9031530913.51
546DTI TBSS MD Superior longitudinal fasciculus LGCST9038461313.48
547Melanomas of skin (PheCode 172.11)GCST9047557813.48
548CD6/EZR ratioGCST9031389013.47
549Crohn's diseaseGCST00413213.45
550NELL2/SEZ6L ratioGCST9031553613.43
551SUMF1 levelsGCST9047078313.43
552Ratio of bis-allylic bonds to double bonds in lipidsGCST9013274413.42
553Asthma, unspecified (mode)FING0000012013.38
554Hypoplasia of dental enamel, including avohilmoFING0000065213.37
555Operation code - hysterectomy | OperationsUKBB0000055913.37
556DTI TBSS L2 Posterior thalamic radiation RGCST9038450413.27
557MICB or MICA levelsGCST9046990513.27
558CD74/NPDC1 ratioGCST9031389513.25
559CDSN/LY6D ratioGCST9031399713.25
560B2M levelsGCST9046840913.23
561ITGB1BP2/TIA1 ratioGCST9031522213.22
562Athlete's foot (PheCode 110.12)GCST9047556313.16
563CEP43/MPHOSPH8 ratioGCST9031401913.16
564DTI autoptx MD slf r tractGCST9038524213.14
565Prospective memory result | Prospective memoryUKBB0000071313.14
566Current SmokerFING0000037113.12
567CWC15 levelsGCST9046892013.09
568ARHGAP25/RNF41 ratioGCST9031334513.09
569Vanillactate levelsGCST9019997813.08
570BCR/FOXO1 ratioGCST9031349013.06
571Belief that own life is meaningful | Happiness and subjective well-beingUKBB0000009013.05
572IPCEF1/SPARC ratioGCST9031518613.01
573IDP dMRI TBSS OD Posterior limb of internal capsule RGCST9000442013.01
574Tryptophan betaine levelsGCST9019981913.01
575ST13 levelsGCST9047075113.00
576CEACAM8/PGLYRP1 ratioGCST9031400312.97
577Symptoms involving digestive system (PheCode 561)GCST9047606912.96
578CC2D1A/STAMBP ratioGCST9031366412.94
579PRKAR1A/SNAP23 ratioGCST9031572812.94
580Acute bronchitisFING0000002112.91
581MAP2K1 levelsGCST9046985112.88
582Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB0000008312.85
583Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING0000077212.80
584ConjunctivitisFING0000034612.79
585Acquired hypothyroidism (PheCode 244.2)GCST9047565012.79
586FUT8/TNFSF14 ratioGCST9031489512.78
587Omega-3 fatty acid levelsGCST9050242212.77
588LAYN/PTPRN2 ratioGCST9031529012.75
589BACH1/SNAP23 ratioGCST9031344612.73
590CCN2/DKK1 ratioGCST9031371012.72
591Cleft hard palate NOSFING0000030612.70
592NAP1L4 levelsGCST9046999812.70
593Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST9030270312.69
594ATP5IF1/LYN ratioGCST9031338912.68
595Regional enteritis (PheCode 555.1)GCST9047606612.67
596Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066875812.64
597Average total household income before tax | HouseholdUKBB0000008112.62
598CRACR2A/LBR ratioGCST9031422812.56
599Other contact dermatitisFING0000099012.56
600IL15/NCR1 ratioGCST9031515012.52
601mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST9047547412.51
602CCL5/TACC3 ratioGCST9031370712.51
603Multiple myelomaGCST9062474712.50
604EDAR/F2R ratioGCST9031457712.46
605Basophil countGCST9000229312.43
606DCTN1/TRIAP1 ratioGCST9031443412.41
607TSC1 levelsGCST9047097212.40
608PRG3 levelsGCST9047032312.37
609Neoplasm of uncertain behavior of skin (PheCode 173)GCST9047558512.37
610Polymyalgia rheumaticaFING0000118812.36
611GIMAP7 levelsGCST9046934512.34
612Skin cancerGCST9047518912.32
613Ceramide (d18:2/24:1) levelsGCST9002468412.31
614CALCOCO1/IRAG2 ratioGCST9031360412.31
615General happiness | Happiness and subjective well-beingUKBB0000028012.30
616DTI autoptx L3 ifo l tractGCST9038520512.29
617MAPRE3 levelsGCST9046985912.29
618ICD10 N97.8: Female infertility of other originGCST9045422512.27
619Ankylosing spondylitis, strict definitionFING0000009012.24
620Ever SmokerFING0000052212.23
621Lymphoid leukemia, chronic (PheCode 204.12)GCST9047561312.18
622Omega-3 fatty acids to total fatty acids percentageGCST9050208712.17
623Mean sphered cell volume (UKB data field 30270)GCST9046808912.14
624Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING0000138812.10
625Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB0000062512.06
626HSPB1 levelsGCST9017931712.05
627Ulcerative colitisGCST9044679512.04
628Lymphocyte percentage of white cellsGCST00463212.01
629SUOX levelsGCST9047078511.99
630mean corpuscular volume (MCV, mean, inv-norm transformed)GCST9047547011.96
631Rosacea (PheCode 695.3)GCST9047617811.95
632Skin color (cheek, ITA value)GCST9050278011.93
633BACH1/CD2AP ratioGCST9031343511.90
634IPCEF1/TBCC ratioGCST9031518811.84
635Principal component-derived dietary pattern 26GCST9013303111.82
636TNFRSF13B/TNFSF13B ratioGCST9031593311.78
637Acute renal failureFING0000003011.78
638Autoimmune hepatitisGCST9001856511.76
639X-11550 levelsGCST9024364811.74
640Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST9047527511.70
6415alpha-pregnan-3beta,20alpha-diol monosulfate (2) levelsGCST9019985411.68
642DAG1/F2R ratioGCST9031437411.64
643ESAM/FUT8 ratioGCST9031471111.62
644FCRL6/KLRD1 ratioGCST9031480711.61
645VEGFB levelsGCST9047103511.60
646Spondylopathies (FG)FING0000132611.60
647TOR1AIP1 levelsGCST9047093511.59
648LY96 levelsGCST9046982311.53
649Non-cancer illness code, self-reported - hiatus hernia | Medical conditionsUKBB0000051511.52
650Fibroblastic disordersFING0000054211.52
651PLAUR levelsGCST9001205111.52
652CXCL5/MESD ratioGCST9031435011.51
653CA1/HMBS ratioGCST9031357311.49
654DTI TBSS L3 Posterior thalamic radiation RGCST9038455211.43
655HBEGF/WWP2 ratioGCST9031503811.43
656CD86 levelsGCST9046865411.42
657DTI TBSS MD External capsule LGCST9038460511.42
658TPSAB1 levelsGCST9047095111.40
659Brain age gapGCST9055803411.40
660Actinic keratosis (PheCode 702.1)GCST9047620411.38
661FOXO1/NFATC1 ratioGCST9031487311.37
662FUT8/RSPO1 ratioGCST9031489111.36
663EDAR/ERBIN ratioGCST9031457511.34
664Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763)GCST9047626811.33
665Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB0000087211.32
666YOD1 levelsGCST9047109011.29
667CRACR2A/IRAG2 ratioGCST9031422711.24
668mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST9047546611.19
669Colitis, primary sclerosing, strict definitionFING0000031311.19
670PPP1R2/TBL1X ratioGCST9031572011.18
671KIR3DL1 levelsGCST9046968711.17
672ITGB7 levelsGCST9046964711.15
673Bifidobacterium catenulatum abundance in stoolGCST9003222411.12
674EDAR/EGF ratioGCST9031457311.11
675Other and unspecified tonsillitisFING0000095411.11
676DTI autoptx L1 cst r tractGCST9038514811.10
677IDP dMRI ProbtrackX L1 ifo rGCST9000425911.08
678EDAR/LAT2 ratioGCST9031458211.08
679Degenerative skin conditions and other dermatoses (PheCode 702)GCST9047620211.06
680Eosinophil percentage of white cells varianceGCST9056569011.06
681aparc-a2009s rh volume S-collat-transv-antGCST9000304811.05
682Other systemic involvement of connective tissue (FG)FING0000111611.01
683UrticariaFING0000140811.00
684Number of days/week walked 10+ minutes | Physical activityUKBB0000053510.99
685ADA levelsGCST9046823110.96
686PRKAB1 levelsGCST9047032410.95
687GBP4 levelsGCST9046931310.94
688IDP dMRI TBSS ISOVF Genu of corpus callosumGCST9000447910.93
689ENO2/PLXNA4 ratioGCST9031466510.91
690CD69/EDAR ratioGCST9031387510.90
691Pilonidal cystFING0000116710.88
692APRT/CD63 ratioGCST9031333410.84
693BCR/ITGB1BP2 ratioGCST9031349410.84
694Prescriptions - antispasmodicUKBB0000066610.83
695Atopic dermatitisGCST9001856410.83
696DTI TBSS MD Superior corona radiata RGCST9038459610.81
697aparc-Desikan rh volume insulaGCST9000283410.79
698T1 FreeSurfer aseg Right-PallidumGCST9038416410.76
699WARS levelsGCST9047106610.75
700Long-standing illness, disability or infirmity | General healthUKBB0000040910.74
701Mean reticulocyte volumeGCST9002597510.74
702DTI autoptx L1 cst l tractGCST9038514710.73
703DBNL/EDAR ratioGCST9031441610.69
704CD27/TNFRSF9 ratioGCST9031377810.64
705Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB0000036910.62
706Dermatomycosis (PheCode 110.2)GCST9047556510.61
707PPM1B levelsGCST9047029610.58
708N-acetylmethionine levelsGCST9020028910.55
709T1 FreeSurfer a2009s lh S postcentral areaGCST9038473410.55
710Volume of right cortical nucleusGCST9047503310.54
711CDH17/PECAM1 ratioGCST9031394210.54
712DTI autoptx L3 ilf l tractGCST9038520710.53
713Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING0000014310.52
714CDKN2D/FOXO1 ratioGCST9031398510.51
715Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST9004183710.50
716Atrial septal defectFING0000012810.49
717Mean reticulocyte volume (UKB data field 30260)GCST9046808810.48
718Mean reticulocyte volumeGCST9000239610.47
719BronchitisFING0000022810.46
720Taking other prescription medications | MedicationUKBB0000081310.45
721ITGB2 levelsGCST9046964410.45
722CXCL16 levelsGCST9024052410.44
723TXNDC15 levelsGCST9047099010.42
724Cervicalgia (PheCode 761)GCST9047626710.42
725Avocado likingGCST9009469410.42
726T1 CAT volume R RightThalamusGCST9038409710.42
727Triacylglycerol_56:6_[M+NH4]1+ levelsGCST9006055310.41
728Ulcerative colitisGCST9046815210.39
729LCN2/PGLYRP1 ratioGCST9031530610.37
730AHCY/HSPA1A ratioGCST9031321110.35
731Mean sphered cell volume | Blood countUKBB0000045210.34
732Educational attainmentGCST00259810.33
733SNAP23/TXLNA ratioGCST9031585710.31
734Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207410.30
735Biological Mother: High blood pressureGCST9047549010.29
736Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING0000014210.28
737Late-onset myasthenia gravisGCST9009346610.27
738THBS2 levelsGCST9047085410.22
739Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB0000046110.21
740LRRC37A2 levelsGCST9046980210.21
741ELOA levelsGCST9046910410.20
742CDH17/SPINT1 ratioGCST9031394410.16
743Ectopic pregnancyFING0000048710.16
744Pollen allergyFING0000117610.16
745CD27 levelsGCST9046861510.14
746Prostate cancerGCST9001868510.14
747Suppurative and unspecified otitis mediaFING0000134610.13
748INSR levelsGCST9046962310.11
749Triacylglycerol_52:4_[M+NH4]1+ levelsGCST9006050810.11
750T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST9032092010.08
751PBLD levelsGCST9047016310.06
752Other dorsopathies, not elsewhere classifiedFING0000104110.03
753HEXIM1/TBL1X ratioGCST9031505310.03
754BTN3A2 levelsGCST9046848110.02
755Red blood cell countGCST9000236410.01
756DTI TBSS L3 Posterior thalamic radiation LGCST903845539.98
757DTI autoptx L3 slf r tractGCST903852159.97
758Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756639.97
759IDP T1 FAST ROIs R front operc cortexGCST900025329.96
760CD27/TNFRSF13B ratioGCST903137779.95
761IL2RA levelsGCST904695859.95
762Overweight, obesity and other hyperalimentation (PheCode 278)GCST904757599.95
763CANT1/ROR1 ratioGCST903136209.93
764Dissection of aortaFING000004679.88
765Irritable bowel syndromeFING000007029.86
766DAB2/FKBP1B ratioGCST903143629.84
767POF1B levelsGCST904702819.84
768Back pain (PheCode 760)GCST904762669.82
769Psoriatic arthritis vs Cutaneous psoriasisGCST902439579.82
770CIAPIN1/SNX9 ratioGCST903140689.81
771CataractsGCST900185949.80
772SNAP29/VEGFC ratioGCST903158629.76
773Skin cancer | neoplasmsUKBB000007729.75
774CA3/HMBS ratioGCST903135849.73
775AHSP/BLVRB ratioGCST903132149.71
776FOXO1/MAP4K5 ratioGCST903148729.70
777APEX1 levelsGCST904683299.69
778DTI TBSS MD Cingulum cingulate gyrus RGCST903846069.69
779CD20 on IgD- CD27- B cellGCST900017549.69
780GMPR2 levelsGCST904693679.68
781IDP dMRI TBSS FA FornixGCST900038829.65
782Alcohol-induced chronic pancreatitisFING000000559.61
783TP53BP1 levelsGCST904709369.60
784FOLR2/HAVCR2 ratioGCST903148659.59
785NFATC3 levelsGCST904700349.59
786DOK2/PDLIM7 ratioGCST903145359.58
787DTI TBSS FA Posterior thalamic radiation RGCST903844089.57
788Uterine fibroidsGCST904619589.54
789TNF/TNFRSF1B ratioGCST903159429.53
790RAP1A levelsGCST904704259.53
791CD27/CD79B ratioGCST903137709.53
792DAPP1/ITGB1BP2 ratioGCST903143889.51
793White blood cell countGCST900259859.49
794APRT/MIF ratioGCST903133369.48
795mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754569.47
796Strenuous sports or other exercisesGCST0061009.46
797CD58/MEGF10 ratioGCST903138539.45
798F2R/TNFRSF14 ratioGCST903147399.44
799C1R levelsGCST904684939.42
800TNFSF13B levelsGCST904709209.41
801mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754509.41
802T1 FreeSurfer BA lh V2 exvivo thicknessGCST903855299.40
803IDP dMRI TBSS L1 Posterior limb of internal capsule LGCST900040949.39
804Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329689.38
805EBAG9/TGFB1 ratioGCST903145709.37
806AXL/IL18BP ratioGCST903134209.35
807DTI TBSS L3 Genu of corpus callosumGCST903845269.34
808Rheumatoid arthritis (PheCode 714.1)GCST904762309.34
809Scar conditions and fibrosis of skin (PheCode 701.2)GCST904761989.33
810EFNA4/TNFRSF9 ratioGCST903146069.32
811Volume of left anterior amygdaloid areaGCST904749379.32
812Hernia abdominopelvic cavityGCST900860879.32
813HEPH levelsGCST904694469.32
814Telomere length (principal component 1)GCST904351449.30
815aparc-a2009s rh area S-collat-transv-antGCST900034209.30
816Fluid intelligence score decline (difference score)GCST905658629.29
817FCRL5 levelsGCST904692089.27
818Renal tubulo-interstitial diseasesFING000012519.27
819CD46/TIMP1 ratioGCST903138379.26
820Mean corpuscular volumeGCST900023929.22
821AHNAK levelsGCST904682619.21
822FOXO1/USP8 ratioGCST903148799.19
823IDP dMRI TBSS OD Posterior limb of internal capsule LGCST900044219.17
824CD84/F2R ratioGCST903139129.13
825wg lh intensity-contrast rostralmiddlefrontalGCST900038189.12
826DTI autoptx L2 slf l tractGCST903851879.12
827Allergic conjunctivitisFING000000679.10
828MED18/TACC3 ratioGCST903154149.09
829IL10 levelsGCST904695469.09
830Number of days/week of vigorous physical activity 10+ minutes | Physical activityUKBB000005349.07
831Dried fruit consumptionGCST901329809.03
832Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney diseaseGCST902651759.01
833Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factorsUKBB000000589.00
834mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST904754468.99
835TP53I3 levelsGCST904709378.98
836CLEC4D/CLEC6A ratioGCST903141098.97
837CDKN2D/TACC3 ratioGCST903139928.97
838KIFBP/LYN ratioGCST903152468.96
839Mean spheric corpuscular volumeGCST900023978.95
840Diseases of esophagus (PheCode 530)GCST904760458.92
841CXCL5/PLXNA4 ratioGCST903143518.92
842PGR levelsGCST904702238.89
843DTI TBSS MD Posterior corona radiata LGCST903845998.89
844VSTM2B levelsGCST904710568.88
845mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST904754428.88
846HTRA2/SIAE ratioGCST903150978.85
847Spondylosis and allied disorders (PheCode 721)GCST904762358.82
848F5 levelsGCST904464668.81
849MED18/TBL1X ratioGCST903154158.81
850DTI TBSS L2 Genu of corpus callosumGCST903844788.80
851Spondylosis without myelopathy (PheCode 721.1)GCST904762368.77
852Other non-epithelial cancer of skin | neoplasmsUKBB000006158.77
853IL32 levelsGCST904695918.77
854Disorders of plasma protein metabolism (PheCode 270.3)GCST904757098.74
855Mean corpuscular hemoglobinGCST900023908.73
856IGBP1 levelsGCST904695218.72
857Pain (PheCode 338)GCST904758368.72
858BAG6/BMP6 ratioGCST903134508.70
859T1 CAT volume L VIIIaGCST903841278.69
860rfMRI connectivity (ICA100 edge 912)GCST900057658.68
861NT5C levelsGCST904700928.68
862CDSN/WFDC12 ratioGCST903139998.68
863EDAR/SNAP23 ratioGCST903145878.67
864FKBP4 levelsGCST904692438.66
865Linoleic acid levelsGCST905020098.66
866SNAP23/TBL1X ratioGCST903158568.65
867MVK/SERPINE1 ratioGCST903155058.65
868Plasma N-acetyltaurine levels in chronic kidney diseaseGCST902656008.64
869CAPG levelsGCST904685378.63
870Phenylacetate levelsGCST901996308.62
871Mean corpuscular volume (UKB data field 30040)GCST904680868.62
872SNX15 levelsGCST904706998.62
873Intrinsic epigenetic age accelerationGCST900142908.61
874Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008468.61
875DIABLO/GRAP2 ratioGCST903144668.60
876Snoring | SleepUKBB000007848.60
877Ulcerative enterocolitisFING000013918.59
878S100A12 levelsGCST904705138.58
879Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney diseaseGCST902646748.58
880TACC3/TBC1D23 ratioGCST903159008.56
881FUT8/TNFSF12 ratioGCST903148948.56
882Citrulline levelsGCST902004038.55
883CDC27 levelsGCST904686648.55
884Cancer of bronchus; lung (PheCode 165.1)GCST904755738.54
885ZNF830 levelsGCST904711028.54
886CALCOCO1/TBC1D5 ratioGCST903136108.54
887Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB000002978.54
888CTSC/PLA2G15 ratioGCST903143118.53
889Volume of left central nucleusGCST904748838.51
890HippSubfield lh volume Whole-hippocampal-headGCST900026888.50
891Takes medication for asthma?GCST904752608.50
892UBXN1 levelsGCST904710048.45
893Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST906685188.45
894LPCAT2/SERPINB8 ratioGCST903153288.45
895GDNF levelsGCST902747928.43
896ECM1 levelsGCST904690658.40
897HLA-A levelsGCST904694578.39
898Atrophic disorders of skinFING000001298.39
899DorsopathiesFING000004738.38
900IDP dMRI TBSS L1 Retrolenticular part of internal capsule RGCST900040958.36
901JCHAIN levelsGCST904696618.35
902CRTAM/KLRD1 ratioGCST903142778.35
903Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82)GCST906685268.35
904IDP dMRI TBSS OD Superior fronto-occipital fasciculus RGCST900044448.34
905Thyroid cancer (PheCode 193)GCST904756008.34
906Neutrophill percentage | Blood countUKBB000004988.34
907DNAJC9 levelsGCST904690188.33
908FUT8/VEGFC ratioGCST903148968.32
909Bread type - Wholemeal or wholegrain | DietUKBB000001078.31
910Father's age | Family historyUKBB000002408.30
911CLEC1B/DAB2 ratioGCST903140868.30
912Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB000006138.30
913N-acetyl-2-aminoadipate levelsGCST902002688.29
914IGSF8/NECTIN2 ratioGCST903151408.29
915Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)FING000010678.29
916Polyp of the female genital tractFING000011908.29
917PSIP1 levelsGCST904703548.28
918DTYMK levelsGCST904690498.27
919TLR4 levelsGCST904708808.22
920Oxalate (ethanedioate) levelsGCST901996728.21
921MAP2K6/TBL1X ratioGCST903153788.20
922CXCL5/PPIB ratioGCST903143528.20
923Methionine sulfone levelsGCST901999618.19
924Other arthritis (FG)FING000009648.18
925Carboplatin drug response (IC50)GCST900117838.18
926PARP1 levelsGCST904701608.17
927Malignant neoplasm, excluding all cancers (controls excluding all cancers)FING000007808.16
928Neutrophill percentage (UKB data field 30200)GCST904680938.16
929Epstein-Barr virus ZEBRA antibody levelsGCST900069018.15
930Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418398.14
931Neutrophil percentage of white cellsGCST900023998.13
932Happiness | Mental healthUKBB000003058.12
933Human herpes virus 7 U14 antibody levelsGCST900069098.08
934Bell's palsyFING000001448.07
935RBP5 levelsGCST904704398.07
936T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903208768.06
937Non-cancer illness year/age first occurred | Medical conditionsUKBB000005238.04
938DTI autoptx MD fma tractGCST903852308.04
939T1 CAT volume R RightPutamenGCST903841018.04
940Handedness (chirality/laterality) - Right-handed | Early life factorsUKBB000003038.03
941Beta-hydroxyisovaleroylcarnitine levelsGCST901998028.02
942HBEGF/PLXNA4 ratioGCST903150368.02
943UROD levelsGCST904710168.01
944IPCEF1/SMAD1 ratioGCST903151858.00
945CNTNAP2/DPP6 ratioGCST903141687.95
946NELL1 levelsGCST902424817.95
947CD163/ICAM1 ratioGCST903137357.95
948Triacylglycerol_56:5_[M+NH4]1+ levelsGCST900605547.92
949Other cancerGCST904751817.89
950Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING000007647.87
951Crohn's diseaseGCST904753187.87
952MICB_MICA/TEK ratioGCST903154467.86
953APBB1IP levelsGCST904683277.85
954NINJ1 levelsGCST904700497.85
955Mean corpuscular haemoglobin (UKB data field 30050)GCST904680847.84
956Body fat rateGCST902786197.83
957GAPDH levelsGCST904693027.83
958AsthmaGCST900860477.81
959EBAG9/TBCC ratioGCST903145687.79
960Principal component-derived dietary pattern 12GCST901330177.78
961How are people in household related to participant - Husband, wife or partner | HouseholdUKBB000003307.78
962TBCA levelsGCST904708127.77
963GPI levelsGCST904693917.74
964Chronic diseases of tonsils and adenoidsFING000002837.73
965NFATC1/SPRY2 ratioGCST903155397.72
966CXCL17/LAMP3 ratioGCST903143407.71
967DTI TBSS L3 Superior corona radiata LGCST903845497.71
968TIA1/USP8 ratioGCST903159207.68
969mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754527.67
970Number of puzzles correctly solved (baseline)GCST905658407.65
971AXIN1/ITGB1BP2 ratioGCST903134127.63
972Dissociative [conversion] disordersFING000004687.63
973ICAM4 levelsGCST904695017.63
974Active to sedentary transition probabilityGCST900614297.61
975DAG1/DBNL ratioGCST903143727.60
976FOXO1/IRAK4 ratioGCST903148707.59
977Actinic keratosisFING000000137.58
978CASP10/ING1 ratioGCST903136257.58
979IRAK1/SPRY2 ratioGCST903151967.56
980NECTIN2/NPDC1 ratioGCST903155287.56
981FUT3 or FUT5 levelsGCST904692807.56
982N-formylmethionine levelsGCST902003437.56
983SLAMF1 levelsGCST904706497.55
984DNAJB14 levelsGCST904272357.55
985CD69/NFATC1 ratioGCST903138797.54
986Dried fruit likingGCST900947567.52
987aseg lh volume Accumbens-areaGCST900026267.52
988Basophil countGCST900187267.51
989CCN2/TACC3 ratioGCST903137177.50
990SPESP1 levelsGCST904707207.49
991LBR/POLR2F ratioGCST903152977.48
992ESAM/TNFRSF14 ratioGCST903147207.47
993Suffer from 'nerves' | Mental healthUKBB000007997.47
994NPDC1/PTGDS ratioGCST903155497.47
995EBAG9/FKBP5 ratioGCST903145647.45
996ITGB1BP2/WASF1 ratioGCST903152247.44
997PXN levelsGCST904703967.44
998DorsalgiaFING000004727.42
999N6,N6-dimethyllysine levels in chronic kidney diseaseGCST902575297.40
1000APP/HBEGF ratioGCST903133247.40